Literature DB >> 18455399

Possibilities for transborder cooperation in breast cancer care in Europe: a comparative analysis regarding the content, quality and evidence use of breast cancer guidelines.

L Wennekes1, R P M G Hermens, K van Heumen, V Runde, H Schoelen, H C H Wollersheim, R P T M Grol, P H M de Mulder, P B Ottevanger.   

Abstract

To encourage transborder cooperation in breast cancer care in Europe, we explored possibilities with the German-Dutch border area as an example. Evidence-based breast cancer guidelines were searched and compared on the: (1) methodological quality (with AGREE (Appraisal of Guidelines for Research and Evaluation)), (2) content of recommendations and (3) evidence use. The methodological quality of the German (n=2) and Dutch guidelines (n=2) was generally sufficient and comparable, although the applicability and the editorial independence were not clearly documented in the Dutch guidelines. Regarding the content analysis, German recommendations were taken as a reference point, because of the highest AGREE scores. Twenty-one of 25 recommendations discussed in both guidelines were corresponding and 4 were different, 32 were not mentioned in the Dutch guideline. The guidelines shared little evidence (< or =11%). We conclude that there are possibilities to encourage transborder cooperation. The clinical context of our results should be examined by measuring the actual care in both countries preferably with quality indicators.

Entities:  

Mesh:

Year:  2008        PMID: 18455399     DOI: 10.1016/j.breast.2008.01.008

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  2 in total

1.  Getting a grip on guidelines: how to make them more relevant for practice.

Authors:  Richard Grol; Chris van Weel
Journal:  Br J Gen Pract       Date:  2009-05       Impact factor: 5.386

Review 2.  Assessment of the quality of clinical practice guidelines in Korea using the AGREE Instrument.

Authors:  Min-Woo Jo; Jin Yong Lee; Nam-Soon Kim; Soo-Young Kim; Seungsoo Sheen; Seon Ha Kim; Sang-Il Lee
Journal:  J Korean Med Sci       Date:  2013-03-04       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.